These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30829190)

  • 1. Effectiveness of a volunteer befriending programme for patients with schizophrenia: randomised controlled trial.
    Priebe S; Chevalier A; Hamborg T; Golden E; King M; Pistrang N
    Br J Psychiatry; 2020 Sep; 217(3):477-483. PubMed ID: 30829190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness of volunteer befriending for improving the quality of life of patients with schizophrenia in Bosnia and Herzegovina - an exploratory randomised controlled trial.
    Sikira H; Janković S; Slatina MS; Muhić M; Sajun S; Priebe S; Džubur Kulenović A
    Epidemiol Psychiatr Sci; 2021 Jun; 30():e48. PubMed ID: 34112279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of one-to-one volunteer support for patients with psychosis: protocol of a randomised controlled trial.
    Priebe S; Pavlickova H; Eldridge S; Golden E; McCrone P; Ockenden N; Pistrang N; King M
    BMJ Open; 2016 Aug; 6(8):e011582. PubMed ID: 27489153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experiences and outcomes of group volunteer befriending with patients with severe mental illness: an exploratory mixed-methods study in Colombia.
    Botero-Rodríguez F; Hernandez MC; Uribe-Restrepo JM; Cabariqe C; Fung C; Priebe S; Gómez-Restrepo C
    BMC Psychiatry; 2021 May; 21(1):239. PubMed ID: 33957896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot randomised controlled trial of befriending by volunteers in people with intellectual disability and depressive symptoms.
    Ali A; McKenzie E; Hassiotis A; Priebe S; Lloyd-Evans B; Jones R; Panca M; Omar R; Finning S; Moore S; Roe C; King M
    J Intellect Disabil Res; 2021 Nov; 65(11):1010-1019. PubMed ID: 34570405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferences for befriending schemes: a survey of patients with severe mental illness.
    Toner S; Cassidy M; Chevalier A; Farreny A; Leverton M; da Costa MP; Priebe S
    BMC Psychiatry; 2018 Mar; 18(1):64. PubMed ID: 29523114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does befriending by trained lay workers improve psychological well-being and quality of life for carers of people with dementia, and at what cost? A randomised controlled trial.
    Charlesworth G; Shepstone L; Wilson E; Thalanany M; Mugford M; Poland F
    Health Technol Assess; 2008 Mar; 12(4):iii, v-ix, 1-78. PubMed ID: 18284895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical effectiveness and cost-effectiveness of body psychotherapy in the treatment of negative symptoms of schizophrenia: a multicentre randomised controlled trial.
    Priebe S; Savill M; Wykes T; Bentall R; Lauber C; Reininghaus U; McCrone P; Mosweu I; Bremner S; Eldridge S; Röhricht F;
    Health Technol Assess; 2016 Feb; 20(11):vii-xxiii, 1-100. PubMed ID: 26869182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An intervention to promote self-management, independence and self-efficacy in people with early-stage dementia: the Journeying through Dementia RCT.
    Mountain G; Wright J; Cooper CL; Lee E; Sprange K; Beresford-Dent J; Young T; Walters S; Berry K; Dening T; Loban A; Turton E; Thomas BD; Young EL; Thompson BJ; Crawford B; Craig C; Bowie P; Moniz-Cook E; Foster A
    Health Technol Assess; 2022 May; 26(24):1-152. PubMed ID: 35536231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocol for the End-of-Life Social Action Study (ELSA): a randomised wait-list controlled trial and embedded qualitative case study evaluation assessing the causal impact of social action befriending services on end of life experience.
    Walshe C; Algorta GP; Dodd S; Hill M; Ockenden N; Payne S; Preston N
    BMC Palliat Care; 2016 Jul; 15():60. PubMed ID: 27412459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early intervention for psychosis.
    Marshall M; Rathbone J
    Cochrane Database Syst Rev; 2006 Oct; (4):CD004718. PubMed ID: 17054213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-to-one befriending for people with intellectual disability and symptoms of depression: protocol for a pilot randomised controlled trial.
    Ali A; Mckenzie E; Hassiotis A; Priebe S; Lloyd-Evans B; Omar R; Jones R; Panca M; Fernandez V; Finning S; Moore S; O'Connor D; Roe C; King M
    BMJ Open; 2020 Jun; 10(6):e033989. PubMed ID: 32565450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BEFRIENding for Depression, Anxiety and Social support in older adults living in Australian residential aged care facilities (BEFRIENDAS): randomised controlled trial protocol.
    Doyle C; Bhar S; Bryant C; Dow B; Dunt D; Mnatzaganian G; O'Connor D; Ratcliffe J; You E; Bagnall AM; Major G; Harper R; Fearn M
    BMC Geriatr; 2021 May; 21(1):305. PubMed ID: 33980168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
    Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT.
    Duffy L; Clarke CS; Lewis G; Marston L; Freemantle N; Gilbody S; Hunter R; Kendrick T; Kessler D; King M; Lanham P; Mangin D; Moore M; Nazareth I; Wiles N; Bacon F; Bird M; Brabyn S; Burns A; Donkor Y; Hunt A; Pervin J; Lewis G
    Health Technol Assess; 2021 Nov; 25(69):1-62. PubMed ID: 34842135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Group cognitive rehabilitation to reduce the psychological impact of multiple sclerosis on quality of life: the CRAMMS RCT.
    Lincoln NB; Bradshaw LE; Constantinescu CS; Day F; Drummond AE; Fitzsimmons D; Harris S; Montgomery AA; das Nair R
    Health Technol Assess; 2020 Jan; 24(4):1-182. PubMed ID: 31934845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How would patients with psychosis like to be in contact with a volunteer: Face-to-face or digitally?
    Pinto da Costa M; Chevalier A; Farreny A; Cassidy M; Leverton M; Toner S; Priebe S
    PLoS One; 2019; 14(5):e0216929. PubMed ID: 31095611
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.